TY - JOUR
T1 - Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration
AU - Uneda, Atsuhito
AU - Kurozumi, Kazuhiko
AU - Fujimura, Atsushi
AU - Fujii, Kentaro
AU - Ishida, Joji
AU - Shimazu, Yosuke
AU - Otani, Yoshihiro
AU - Tomita, Yusuke
AU - Hattori, Yasuhiko
AU - Matsumoto, Yuji
AU - Tsuboi, Nobushige
AU - Makino, Keigo
AU - Hirano, Shuichiro
AU - Kamiya, Atsunori
AU - Date, Isao
N1 - Funding Information:
We thank Dr. Hiroaki Wakimoto (Massachusetts General Hospital, Boston, MA) for providing patient-derived GBM primary cultures MGG4, MGG8, MGG18, and MGG23. We thank Dr. Dinorah Friedmann-Morvinski (Tel Aviv University, Tel Aviv, Israel) for providing the vector plasmid (pTomo-HrasV12-IRES-GFP-shp53). We thank M. Arao and Y. Ukai for technical assistance. We also thank Mitchell Arico from Edanz Group (https://en-author-services.edanzgroup.com/ac) for editing a draft of this manuscript.
Funding Information:
This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) projects from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (20K17969 to A.U., 17K10865 to K.K., 20K07618 to A.F., 20K17931 to Y.S., 18K16560 to K.F., and 17H04303 to I.D.), the Japan Agency for Medical Research and Development (AMED) (18072932 and 20318557 to A.F.), and the Ryobi Teien Memory Foundation for biological research (to A.U.).
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Glioblastoma (GBM) is the most lethal primary brain tumor characterized by significant cellular heterogeneity, namely tumor cells, including GBM stem-like cells (GSCs) and differentiated GBM cells (DGCs), and non-tumor cells such as endothelial cells, vascular pericytes, macrophages, and other types of immune cells. GSCs are essential to drive tumor progression, whereas the biological roles of DGCs are largely unknown. In this study, we focused on the roles of DGCs in the tumor microenvironment. To this end, we extracted DGC-specific signature genes from transcriptomic profiles of matched pairs of in vitro GSC and DGC models. By evaluating the DGC signature using single cell data, we confirmed the presence of cell subpopulations emulated by in vitro culture models within a primary tumor. The DGC signature was correlated with the mesenchymal subtype and a poor prognosis in large GBM cohorts such as The Cancer Genome Atlas and Ivy Glioblastoma Atlas Project. In silico signaling pathway analysis suggested a role of DGCs in macrophage infiltration. Consistent with in silico findings, in vitro DGC models promoted macrophage migration. In vivo, coimplantation of DGCs and GSCs reduced the survival of tumor xenograft-bearing mice and increased macrophage infiltration into tumor tissue compared with transplantation of GSCs alone. DGCs exhibited a significant increase in YAP/TAZ/TEAD activity compared with GSCs. CCN1, a transcriptional target of YAP/TAZ, was selected from the DGC signature as a candidate secreted protein involved in macrophage recruitment. In fact, CCN1 was secreted abundantly from DGCs, but not GSCs. DGCs promoted macrophage migration in vitro and macrophage infiltration into tumor tissue in vivo through secretion of CCN1. Collectively, these results demonstrate that DGCs contribute to GSC-dependent tumor progression by shaping a mesenchymal microenvironment via CCN1-mediated macrophage infiltration. This study provides new insight into the complex GBM microenvironment consisting of heterogeneous cells.
AB - Glioblastoma (GBM) is the most lethal primary brain tumor characterized by significant cellular heterogeneity, namely tumor cells, including GBM stem-like cells (GSCs) and differentiated GBM cells (DGCs), and non-tumor cells such as endothelial cells, vascular pericytes, macrophages, and other types of immune cells. GSCs are essential to drive tumor progression, whereas the biological roles of DGCs are largely unknown. In this study, we focused on the roles of DGCs in the tumor microenvironment. To this end, we extracted DGC-specific signature genes from transcriptomic profiles of matched pairs of in vitro GSC and DGC models. By evaluating the DGC signature using single cell data, we confirmed the presence of cell subpopulations emulated by in vitro culture models within a primary tumor. The DGC signature was correlated with the mesenchymal subtype and a poor prognosis in large GBM cohorts such as The Cancer Genome Atlas and Ivy Glioblastoma Atlas Project. In silico signaling pathway analysis suggested a role of DGCs in macrophage infiltration. Consistent with in silico findings, in vitro DGC models promoted macrophage migration. In vivo, coimplantation of DGCs and GSCs reduced the survival of tumor xenograft-bearing mice and increased macrophage infiltration into tumor tissue compared with transplantation of GSCs alone. DGCs exhibited a significant increase in YAP/TAZ/TEAD activity compared with GSCs. CCN1, a transcriptional target of YAP/TAZ, was selected from the DGC signature as a candidate secreted protein involved in macrophage recruitment. In fact, CCN1 was secreted abundantly from DGCs, but not GSCs. DGCs promoted macrophage migration in vitro and macrophage infiltration into tumor tissue in vivo through secretion of CCN1. Collectively, these results demonstrate that DGCs contribute to GSC-dependent tumor progression by shaping a mesenchymal microenvironment via CCN1-mediated macrophage infiltration. This study provides new insight into the complex GBM microenvironment consisting of heterogeneous cells.
KW - CCN1
KW - Differentiated glioblastoma cell
KW - Glioblastoma
KW - Glioblastoma stem cell
KW - Glioma
KW - Macrophage
KW - Mesenchymal subtype
KW - Microenvironment
KW - TEAD
KW - YAP/TAZ
UR - http://www.scopus.com/inward/record.url?scp=85101231243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101231243&partnerID=8YFLogxK
U2 - 10.1186/s40478-021-01124-7
DO - 10.1186/s40478-021-01124-7
M3 - Article
C2 - 33618763
AN - SCOPUS:85101231243
SN - 2051-5960
VL - 9
JO - Acta neuropathologica communications
JF - Acta neuropathologica communications
IS - 1
M1 - 29
ER -